Oxaliplatin and Capecitabine-Based Chemoradiotherapy for Gastric Cancer-An Extended Phase I MARGIT and AIO Trial

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 142-147

  Hofheinz, Ralf Dieter ^a,b   Wenz, Frederik ^b   Lukan, Nadine ^a   Mai, Sabine ^b,c   Kripp, Melanie ^a   Staiger, Wilko ^b   Schwarzbach, Matthias ^b   Willeke, Frank ^b,d   Möhler, Markus ^e   Post, Stefan ^b   Hochhaus, Andreas ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Interdisziplinäres Tumorzentrum Mannheim ITM   (Germany)

^d St Marien Krankenhaus Siegen gem GmbH   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Capecitabine; Gastric cancer; Oxaliplatin; Radiochemotherapy

Indexed keywords

CHEMOTHERAPY; RADIOTHERAPY;

BEFORE AND AFTER; CAPECITABINE; CHEMORADIATION; CHEMORADIOTHERAPY; FLUOROURACIL; FOUR CYCLES; GASTRIC CANCER; GASTROESOPHAGEAL JUNCTIONS; INDUCTION CHEMOTHERAPIES; MAXIMUM TOLERATED DOSES; OXALIPLATIN; PHASE I; RADIOCHEMOTHERAPY;

TOXICITY;

CAPECITABINE; OXALIPLATIN;

ABDOMINAL CRAMP; ADULT; AGED; ANOREXIA; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; HYPOKALEMIA; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LIVER TOXICITY; LOWER ESOPHAGUS SPHINCTER; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SKIN MANIFESTATION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS;

EID: 57649195034     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.033     Document Type: Article

References (28)

1. Hermans J., Bonenkamp J.J., Boon M.C., et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11 (1993) 1441-1447
2. Earle C.C., and Maroun J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials. Eur J Cancer 35 (1999) 1059-1064
3. Gianni L., Panzini I., Tassinari D., et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 12 (2001) 1178-1180
4. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11 (2000) 837-843
5. Janunger K.G., Hafstrom L., and Glimelius B. Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 168 (2002) 597-608
6. Boige V., Pignon J., Saint-Aubert B., et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol ASCO Annual Meeting Proceedings Part I 25 No. 18S (2007) 4510
7. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy vs surgery alone for resectable gastresophageal cancer. N Engl J Med 355 (2006) 11-20
8. Gunderson L.L., and Sosin H. Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8 (1982) 1-11
9. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastresophageal junction. N Engl J Med 345 (2001) 725-730
10. Cunningham D., Starling N., Rao S., et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358 (2008) 36-46
11. Kang Y., Kang W.K., Shin D.B., et al. Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results. J Clin Oncol ASCO Annual Meeting Proceedings Part I 24 No. 18S (2006) LBA4018
12. Al-Batran S., Hartmann J., Probst S., et al. A randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP). J Clin Oncol ASCO Annual Meeting Proceedings Part I 24 18S (2006) LBA4016
13. Smalley S.R., Gunderson L., Tepper J., et al. Gastric surgical adjuvant radiotherapy consensus report: Rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52 (2002) 283-293
14. Wieland P., Dobler B., Mai S., et al. IMRT for postoperative treatment of gastric cancer: Covering large target volumes in the upper abdomen: A comparison of a step-and-shoot and an arc therapy approach. Int J Radiat Oncol Biol Phys 59 (2004) 1236-1244
15. Lohr F., Dobler B., Mai S., et al. Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT. Strahlenther Onkol 179 (2003) 557-563
16. Coburn N.G., Guller U., Baxter N.N., et al. Adjuvant therapy for resected gastric cancer-rapid, yet incomplete adoption following results of Intergroup 0116 trial. Int J Radiat Oncol Biol Phys 70 (2008) 1073-1080
17. Kim S., Lim D.H., Lee J., et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63 (2005) 1279-1285
18. Hundahl S.A., Macdonald J.S., Benedetti J., and Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9 (2002) 278-286
19. Kollmannsberger C., Budach W., Stahl M., et al. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: Two cooperative phase II studies of the AIO/ARO/ACO. Ann Oncol 16 (2005) 1326-1333
20. Jansen E.P., Boot H., Dubbelman R., et al. Postoperative chemoradiotherapy in gastric cancer-a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer 97 (2007) 712-716
21. Jansen E.P., Boot H., Saunders M.P., et al. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1424-1428
22. Rave-Fränk M., Schmidberger H., Christiansen H., et al. Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells. Int J Radiat Biol 83 (2007) 41-47
23. Cividalli A., Ceciarelli F., Livdi E., et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule. Int J Radiat Oncol Biol Phys 52 (2002) 1092-1098
24. Dunst J., Reese T., Sutter T., et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20 (2002) 3983-3991
25. Khushulani N.I., Leichman C.G., Proulx G., et al. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: Report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20 (2002) 2844-2850
26. Sawada N., Ishikawa T., Sekiguchi F., et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5 (1999) 2948-2953
27. Rödel C., Grabenbauer G.G., Papadopoulos T., et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
28. Ryan D.P., Niedzwiecki D., Hollis D., et al. Cancer and Leukemia Group B 89901: Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 24 (2006) 2557-2562